Sangfelt O

Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik A, Holmberg KO, Bolin S, ..., Weishaupt H, Swartling FJ

- - (-) - [2023-03-31; online 2023-03-31]

Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik A, Holmberg KO, Bolin S, ..., Weishaupt H, Swartling FJ

- - (-) - [2023-03-31; online 2023-03-31]

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.

Borgenvik A, Holmberg KO, Bolin S, ..., Weishaupt H, Swartling FJ

Cancer Res. 82 (24) 4586-4603 [2022-12-16; online 2022-10-12]

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.

Brunner A, Suryo Rahmanto A, Johansson H, ..., Larsson LG, Sangfelt O

Elife 9 (-) - [2020-07-06; online 2020-07-06]

Author response: PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer

Brunner A, Suryo Rahmanto A, Johansson H, ..., Larsson LG, Sangfelt O

- - (-) - [2020-06-22; online 2020-06-22]

Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence.

Suryo Rahmanto A, Swartling FJ, Sangfelt O

Mol Cell Oncol 4 (1) e1252871 [2016-11-08; online 2016-11-08]

FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.

Suryo Rahmanto A, Savov V, Brunner A, ..., Swartling FJ, Sangfelt O

EMBO J. 35 (20) 2192-2212 [2016-10-17; online 2016-09-13]